Am J Transplant, Volume 22, Suppl 3 Archives - Page 157 of 190 - ATC Abstracts

2022 American Transplant Congress
Rhinovirus Infection in Solid Organ Transplant Recipients
G. Motoa¹, M. A. Mendoza¹, M. Raja¹, J. Simkins², S. Anjan², E. Martin², A. Phancao², N. Sinha², L. Abbo¹, G. Guerra², Y. Natori²
¹Jackson Memorial Hospital / University of Miami, Miami, FL, ²Miami Transplant Institute – University of Miami, Miami, FL
*Purpose: Respiratory viral infections are one of the most common infections in solid organ transplant recipients (SOTR), causing significant morbidity and mortality. Limited data is…
2022 American Transplant Congress
Diagnosis of Acute Graft Rejection After Kidney Transplantation Using Metabolome Analysis by Liquid Biopsy Approach
H. Iwamoto¹, O. Konno¹, Y. Kihara¹, M. Okihara¹, I. Akashi¹, T. Ueno¹, M. Sugimoto²
¹Department of Kidney Transplantation Surgery, Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan, ²Research and Development Center for Minimally Invasive and Preemptive Medicine, Tokyo Medical University, Tokyo, Japan
*Purpose: Presently, a definitive diagnosis of organ dysfunction after transplantation (such as acute rejection) is dependent on conventional histopathological evaluation using an invasive biopsy procedure…
2022 American Transplant Congress
Do Early Trends of Donor-Derived Cell Free DNA Predict Long Term Kidney Allograft Outcomes?
S. Park¹, K. Guo², L. Zhao², C. Rebello², J. Friedewald²
¹Transplant Nephrology, Northwestern University, Chicago, IL, ²Northwestern University, Chicago, IL
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) has been studied and established for acute rejection detection but the impact of early dd-cfDNA changes on graft outcomes has…
2022 American Transplant Congress
Predictive Value of Abnormal Hemodynamic Response to Dobutamine Stress Echocardiography in Liver Transplant Recipients
M. Groose, A. Peotter, L. Hammel
University of Wisconsin Hospitals and Clinics, Madison, WI
*Purpose: Dobutamine stress echocardiography (DSE) is an effective tool for perioperative cardiac risk stratification in patients without end-stage liver disease (ESLD). However, DSE is frequently…
2022 American Transplant Congress
Resource Utilization in Liver Transplant Patients Based on Psychological Evaluation of High Risk vs. Non-High Risk
K. Barber¹, D. Chism², R. Sauls³, R. Shargo³, M. Gosselin⁴, S. Mohammed³, K. Robichaux³, A. Kumar⁵, J. Buggs¹
¹Transplant Surgery, Tampa General Hospital, Tampa, FL, ²Lake Erie College of Osteopathic Medicine, Bradenton, FL, ³University of South Florida, Tampa, FL, ⁴University of Tampa, Tampa, FL, ⁵Morsani College of Medicine, University of South Florida, Tampa, FL
*Purpose: Psychological evaluation in liver transplant candidates helps to determine suitability. The psychological risk assessment results in the characterization of either low, medium, or high…
2022 American Transplant Congress
DCD Liver Grafts Can Safely be Used for Recipients with Grade 1-2 Portal Vein Thrombosis
L. A. Mercado¹, H. K. Bhangu¹, K. R. Musto², K. D. Watt³, B. Taner⁴, C. B. Rosen⁵, T. Taner⁵, L. Yang¹, D. M. Harnois¹, J. D. LeGout⁶, K. P. Croome⁴
¹Liver Transplant, Mayo Clinic, Jacksonville, FL, ²Transplant, Mayo Clinic, Jacksonville, FL, ³Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, ⁴Transplant Surgery, Mayo Clinic, Jacksonville, FL, ⁵Transplant Surgery, Mayo Clinic, Rochester, MN, ⁶Radiology, Mayo Clinic, Jacksonville, FL
*Purpose: Limited data is available in the literature regarding patients with portal vein thrombosis (PVT) receiving a liver transplant (LT) from a donation after circulatory…
2022 American Transplant Congress
Impact of Donor-to-Recipient Body Surface Area Ratio on Graft Survival and Mortality Following Deceased Donor Liver Transplants
S. Radomski, L. Zeiser, A. Massie, S. Ottmann, D. Segev, E. King
Surgery, Johns Hopkins University, Baltimore, MD
*Purpose: The impact of size mismatch on graft survival in living donor liver transplant is well established but is not a common concern in deceased…
2022 American Transplant Congress
National Landscape of the Utilization of Living Donor Liver Allografts in Redo Liver Transplantation
J. I. López, K. Nijhar, J. Mitchell, L. Bowles Zeiser, K. Key, A. Asamoah-Mensah, A. Thomas, R. Haneda, S. K. Romano, J. Huang, A. Massie, A. M. Cameron, D. L. Segev, E. A. King
Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: To examine the use of living donor liver allografts in patient’s requiring redo liver transplantation.*Methods: Using data from SRTR 2009-2020, we evaluated the number…
2022 American Transplant Congress
Impact of Graft Type, Presence and Type of Inflammatory Bowel Disease on Outcomes Following Liver Transplantation for Primary Sclerosing Cholangitis
S. Kumar¹, S. Lin², J. D. Schold³
¹Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, ²Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, ³Center for Populations Health Research, Cleveland Clinic Foundation, Cleveland, OH
*Purpose: In Primary sclerosing cholangitis (PSC), concerns exist regarding outcomes following donation after circulatory death (DCD) liver transplantation (LT) due to risk of ischemic cholangiopathy…
2022 American Transplant Congress
An In Depth Assessment of Unsuccessful DCD Donor Procurement Attempts: Areas for Improvement
M. Rosenzweig, M. Finotti, E. Martinez, S. Lee, A. Gupta, A. Wall, J. Bayer, H. Fernandez, N. Onaca, R. Ruiz, G. J. McKenna
Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX
*Purpose: DCD donors are a key way to expand allograft supply but an aggressive strategy of pursuing DCD liver allografts is associated with significant number…